SEC Form 4 · accession 0000891293-15-000007

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Corporate Development

Period of report

Feb 4, 2015

Accepted (ET)

Feb 6, 2015 · 6:42 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000891293

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 4, 2015	S	1,100	$2.20	D	870,123	D
Common Stock	Feb 4, 2015	S	200	$2.205	D	869,923	D
Common Stock	Feb 4, 2015	S	1,900	$2.21	D	868,023	D
Common Stock	Feb 4, 2015	S	1,100	$2.215	D	866,923	D
Common Stock	Feb 4, 2015	S	3,700	$2.22	D	863,223	D
Common Stock	Feb 4, 2015	S	800	$2.225	D	862,423	D
Common Stock	Feb 4, 2015	S	1,600	$2.23	D	860,823	D
Common Stock	Feb 4, 2015	S	300	$2.235	D	860,523	D
Common Stock	Feb 4, 2015	S	500	$2.24	D	860,023	D
Common Stock	Feb 4, 2015	S	600	$2.25	D	859,423	D
Common Stock	Feb 4, 2015	S	200	$2.26	D	859,223	D

No Table II lines on this filing.